Results 51 to 60 of about 4,530 (213)

Contribution of the OC Sensor immunoassay in comparison to the Hemoccult II guaiac-test in organized colorectal cancer screening

, 2019
Colorectal cancer (CRC) is a major cause of cancer-related death of worldwide with high incidence and mortality rate, accessible to a screening program in France, first with guaiac- based fecal occult blood test (g-FOBT) then with fecal immunochemical ...
C. Vitellius, Laly, Margot, Saulnier, Patrick, M. Laly, A.S. Banaszuk, Caroli-Bosc, François-Xavier, N. Cornet, S. Bertrais, Vitellius, Carole, Deherce, Isabelle, P. Saulnier, F.X. Caroli-Bosc, Cornet, Nathanaëlle, I. Deherce, Banaszuk, Anne-Sophie, Bertrais, Sandrine   +15 more
core   +1 more source

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026

CA: A Cancer Journal for Clinicians, Volume 76, Issue 3, May/June 2026.
ABSTRACT Colorectal cancer (CRC) is a leading cause of cancer incidence and mortality in the United States, with rates recently increasing among adults younger than 65 years. In 2018, the American Cancer Society (ACS) lowered the recommended age to initiate screening for average‐risk adults to age 45 years.
Andrew M. D. Wolf, Richard M. Hoffman, Louise C. Walter, Charnita Zeigler‐Johnson, Timothy R. Church, Carmen E. Guerra, Elena B. Elkin, Ruth Etzioni, Abbe Herzig, Kevin C. Oeffinger, Rebecca B. Perkins, Sana Raoof, Ya‐Chen Tina Shih, Steven J. Skates, Tyler B. Kratzer, Deana Manassaram‐Baptiste, Robert A. Smith   +16 more
wiley   +1 more source

Adverse events of colonoscopy in a colorectal cancer screening program with fecal immunochemical testing: a population-based observational study

Endoscopy International Open, 2021
Background and study aims The aim of this study was to assess adverse events (AEs) associated with colonoscopy in the French colorectal cancer screening program with fecal occult blood test (FOBT).
Bernard Denis, Isabelle Gendre, Sarah Weber, Philippe Perrin   +3 more
doaj   +1 more source

Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. [PDF]

PLoS ONE, 2014
Colorectal cancer (CRC) is a leading cause of cancer related death in Europe and the USA. There is no universally accepted effective non-invasive screening test for CRC.
Ramesh P Arasaradnam, Michael J McFarlane, Courtenay Ryan-Fisher, Erik Westenbrink, Phoebe Hodges, Matthew G Thomas, Samantha Chambers, Nicola O'Connell, Catherine Bailey, Christopher Harmston, Chuka U Nwokolo, Karna D Bardhan, James A Covington   +12 more
doaj   +1 more source

Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme [PDF]

, 2021
Objective: Faecal immunochemical tests (FIT) are replacing guaiac faecal occult blood tests (FOBT) in colorectal cancer (CRC) screening. Data from the first year of FIT screening were compared with those from FOBT screening and assumptions based on a ...
Strachan, Judith, Brand, Jess, Clark, Gavin R. C., Fraser, Callum, Steele, Robert J. C., Carey, Francis, Irvine, Audrey, Godfrey, Thomas G., Anderson, Annie S.; id_orcid, McPherson, Alisson   +9 more
core   +1 more source

Challenges in the future of cancer screening

International Journal of Cancer, Volume 158, Issue 8, Page 2013-2022, 15 April 2026.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial

Gastroenterology Research and Practice, 2016
Objective. To test the effectiveness of adding a narrative leaflet to the current information material delivered by the NHS English colorectal cancer (CRC) screening programme on reducing socioeconomic inequalities in uptake. Participants. 150,417 adults
Lesley M. McGregor, Christian von Wagner, Wendy Atkin, Ines Kralj-Hans, Stephen P. Halloran, Graham Handley, Richard F. Logan, Sandra Rainbow, Steve Smith, Julia Snowball, Mary C. Thomas, Samuel G. Smith, Gemma Vart, Rosemary Howe, Nicholas Counsell, Allan Hackshaw, Stephen Morris, Stephen W. Duffy, Rosalind Raine, Jane Wardle   +19 more
doaj   +1 more source

Synchronous Gastric Metastasis From Sigmoid Colon Cancer: A Case Report

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Colorectal cancer is the third most common cancer worldwide, and as such is a significant global health concern. Distant metastases of colorectal cancer to the lung, liver, and bone are well documented, while gastrointestinal tract (GIT) metastases are very rare. Herein, we report a case of gastric metastasis from sigmoid colon cancer.
Seung Jong Oh, Seul‐Gi Oh, Sun Keun Choi   +2 more
wiley   +1 more source

Endoscopic Appearance of Oropharyngeal and Upper GI Kaposi’s Sarcoma in an Immunocompromised Patient

Case Reports in Gastrointestinal Medicine, 2017
Introduction. Kaposi’s sarcoma (KS) usually manifests as a cutaneous disease but GI manifestation is often rare. It is associated with human herpes virus-8 (HHV-8) and seen in immunocompromised patients.
Umar Darr, Anas Renno, Zubair Khan, Turki Alkully, Maitham A. Moslim, Sehrish Kamal, Ali Nawras   +6 more
doaj   +1 more source

Geographical Disparities in Faecal Immunochemical Test‐Based Colorectal Cancer Screening Participation and Positivity Rates: A Systematic Review and Meta‐Analysis

Health Promotion Journal of Australia, Volume 37, Issue 2, April 2026.
ABSTRACT Background People in rural and remote areas often participate less actively in colorectal cancer (CRC) prevention practices, including faecal immunochemical testing (FIT). However, the evidence on this is limited. Objective The aim of this systematic review and meta‐analysis was to summarise geographical disparities in participation and ...
Melkalem Mamuye Azanaw, Erin L. Symonds, Geraldine Laven‐Law, Wudneh Simegn Belay, Syme Aftab, Muktar B. Ahmed, Molla M. Wassie   +6 more
wiley   +1 more source